Prelude Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Sell |
|
|||||
|
2025
Q1 | $912K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.16M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $38K | Buy |
|
|||||
|
2018
Q1 | $35K | Buy |
|
|||||
|
2017
Q4 | $42K | Sell |
|
|||||
|
2017
Q3 | $59K | Buy |
|
|||||
|
2017
Q2 | $76K | Buy |
|
|||||
|
2017
Q1 | $64K | Buy |
|
|||||
|
2016
Q4 | $13K | Buy |
|